Form 4: CME Group Officer Sells $1.98M in Stock

Derek Sammann, Senior Managing Director and Global Head of Commodities Markets at CME Group Inc., reported the sale of 7,200 Class A common shares for approximately $1.98 million under a Rule 10b5-1 plan.

Summary

• Derek Sammann, Senior Managing Director and Global Head of Commodities Markets at CME Group Inc., filed a Form 4 reporting changes in beneficial ownership.
• On November 6, 2025, 2,300 shares of Class A Common Stock were transferred from direct ownership to a revocable living trust at a price of $0 per share.
• On November 20, 2025, a total of 7,200 shares of Class A Common Stock were disposed of through sales.
• This included 5,886 shares sold indirectly by the trust at a price of $275.65 per share.
• An additional 1,314 shares were sold indirectly by the spouse at a price of $275.74 per share.
• The total value of shares sold on November 20, 2025, was approximately $1,985,297.86.
• Following these transactions, Sammann beneficially owns 8,683 shares directly, 11,028 shares indirectly by trust, and 7,022 shares indirectly by spouse, totaling 26,733 shares.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: Neutral. While an insider sale can be perceived negatively, the disclosure of a 10b5-1 plan suggests the sale was pre-planned and not based on new, non-public information, thus mitigating negative sentiment.

Positives

• The transactions were made pursuant to a Rule 10b5-1 plan, indicating pre-scheduled sales rather than a reaction to recent non-public information, which mitigates potential negative interpretations of insider selling.

Negatives

• An insider, Derek Sammann, sold a significant number of shares (7,200 shares) totaling approximately $1.98 million, which can sometimes be perceived negatively by the market.

Future Outlook

N/A

Industry Context

N/A

Related Party Transactions

• Transfer of 2,300 shares of Class A Common Stock from direct ownership to the reporting person's revocable living trust on November 6, 2025.
• Sale of 1,314 shares of Class A Common Stock indirectly by the reporting person's spouse on November 20, 2025.

Stakeholder Impact

• Shareholders: Insider sales, even if pre-planned, can sometimes be viewed with caution, though the Rule 10b5-1 plan mitigates the potential for negative interpretation. The reporting person retains substantial beneficial ownership.

Key Dates

Recommendation

The filing reports an insider sale, which typically might raise concerns. However, the transaction was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not a reaction to recent material non-public information. This mitigates the negative signal of an insider sale. Without additional information on the company's performance or market conditions, a 'hold' recommendation is appropriate as this filing alone does not provide a strong catalyst for a 'buy' or 'sell' decision.

Keywords

CME Group, CME, Insider Trading, Form 4, Stock Sale, Derek Sammann, Commodities Markets, SEC Filing, Executive Compensation, Rule 10b5-1